Good's Syndrome: Time to Move on From Reviewing the Past

Area of Science:

• Immunology
• Pathophysiology
• Rare Diseases

Background:

• Good's syndrome (GS) is a rare adult immune deficiency characterized by hypogammaglobulinemia and thymoma.
• Its pathophysiology has been poorly understood for decades, with ongoing debate on its distinction from Common Variable Immune Deficiency (CVID).

Purpose of the Study:

• To review current knowledge on Good's syndrome pathophysiology.
• To identify research gaps and propose a new research direction to resolve controversies surrounding GS and CVID.

Main Methods:

• Review of existing literature including case reports, retrospective, and cross-sectional studies.
• Analysis of demographic features and immune phenotypes distinguishing GS from CVID.

Main Results:

• GS predominantly affects adults and shows a severe reduction or absence of peripheral B cells.
• CVID occurs in children and adults, typically with normal/reduced peripheral B cells but low memory B cells.
• Differences in T cell dysregulation and hematologic cytopenias also distinguish GS from CVID.

Conclusions:

• GS and CVID exhibit distinct demographic and immune phenotypes, suggesting fundamental differences in pathophysiology.
• Current understanding of GS is limited by data inconsistencies; a shift towards robust mechanistic studies is proposed.
• A coordinated research approach is essential to clarify GS pathophysiology and resolve diagnostic controversies.